BIRC3 Polyclonal Antibody

Cat.#: 160161

Special Price 174.2 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    BIRC3 Polyclonal Antibody
  • Documents
  • Description
    Polyclonal antibody to BIRC3
  • Tested applications
    WB, IF
  • Species reactivity
    Human
  • Alternative names
    BIRC3 antibody; AIP1 antibody; API2 antibody; CIAP2 antibody; HAIP1 antibody; HIAP1 antibody; MALT2 antibody; MIHC antibody; RNF49 antibody; c-IAP2 antibody; baculoviral IAP repeat containing 3 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Antigen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-180 of human BIRC3 (NP_001156.1).
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • Storage instructions
    Store at -20℃. Avoid freeze / thaw cycles.
  • Applications
    WB 1:200 - 1:2000
    IF 1:50 - 1:200
  • Validations

    Western blot - BIRC3 Polyclonal Antibody

    Western blot - BIRC3 Polyclonal Antibody

    Western blot analysis of extracts of U-937 cells, using BIRC3 antibody .Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.

    Immunofluorescence - BIRC3 Polyclonal Antibody

    Immunofluorescence - BIRC3 Polyclonal Antibody

    Immunofluorescence analysis of U2OS cells using BIRC3 antibody at dilution of 1:100. Blue: DAPI for nuclear staining.

  • Background
    Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"